BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30626933)

  • 1. The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia.
    Liu Y; Wang L; Shi H
    Hypertens Res; 2019 Jul; 42(7):928-934. PubMed ID: 30626933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elabela and Apelin actions in healthy and pathological pregnancies.
    Eberlé D; Marousez L; Hanssens S; Knauf C; Breton C; Deruelle P; Lesage J
    Cytokine Growth Factor Rev; 2019 Apr; 46():45-53. PubMed ID: 30910349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apelinergic-axis in human preeclamptic pregnancies: A systematic review.
    Georgiadou D; Afink GB; van Dijk M
    Pregnancy Hypertens; 2019 Jul; 17():148-157. PubMed ID: 31487633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of apelin and Elabela in cardiovascular disease.
    Gao S; Chen H
    Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ.
    Zhou L; Sun H; Cheng R; Fan X; Lai S; Deng C
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E773-E781. PubMed ID: 30860880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Apelinergic System in Pregnancy.
    Pécheux O; Correia-Branco A; Cohen M; Martinez de Tejada B
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential Role of the ELABELA-APJ Signaling Pathway in Cardiovascular System Development and Diseases.
    Zhou S; Wang J; Wang Q; Meng Z; Peng J; Song W; Zhou Y; Chen S; Chen F; Sun K
    J Cardiovasc Pharmacol; 2020 Apr; 75(4):284-291. PubMed ID: 32000202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
    Kuba K; Sato T; Imai Y; Yamaguchi T
    Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension.
    Song J; Tang J; Zhang Z; Liu Y; Zhong J
    Chin Med J (Engl); 2022 May; 135(9):1019-1026. PubMed ID: 34608073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin, APJ, and ELABELA: Role in Placental Function, Pregnancy, and Foetal Development-An Overview.
    Dawid M; Mlyczyńska E; Jurek M; Respekta N; Pich K; Kurowska P; Gieras W; Milewicz T; Kotula-Balak M; Rak A
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological functions of Elabela, a novel endogenous ligand of APJ receptor.
    Xu J; Chen L; Jiang Z; Li L
    J Cell Physiol; 2018 Sep; 233(9):6472-6482. PubMed ID: 29350399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elabela-apelin-12, 17, 36/APJ system promotes platelet aggregation and thrombosis via activating the PANX1-P2X7 signaling pathway.
    Chen Z; Luo X; Liu M; Jiang J; Li Y; Huang Z; Wang L; Cao J; He L; Huang S; Hu H; Li L; Chen L
    J Cell Biochem; 2023 Apr; 124(4):586-605. PubMed ID: 36855998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elabela, a newly discovered APJ ligand: Similarities and differences with Apelin.
    Zhang Y; Wang Y; Lou Y; Luo M; Lu Y; Li Z; Wang Y; Miao L
    Peptides; 2018 Nov; 109():23-32. PubMed ID: 30267732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and signaling pathways of Elabela in the cardiovascular system.
    Zhou M; Wu Y
    Peptides; 2022 Jan; 147():170674. PubMed ID: 34718064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice.
    Ho L; van Dijk M; Chye STJ; Messerschmidt DM; Chng SC; Ong S; Yi LK; Boussata S; Goh GH; Afink GB; Lim CY; Dunn NR; Solter D; Knowles BB; Reversade B
    Science; 2017 Aug; 357(6352):707-713. PubMed ID: 28663440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
    Huang Z; He L; Chen Z; Chen L
    J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to higher concentrations of exogenous ELABELA causes HTR-8/SVneo trophoblast cell dysfunction: A possible pathogenesis of pre-eclampsia.
    Liu D; Luo D; Ge H; Zhang C; Wei S; Liang D; Tang D; Li J; Lin Y
    Pregnancy Hypertens; 2022 Dec; 30():181-188. PubMed ID: 36308998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elabela/Toddler and apelin bind differently to the apelin receptor.
    Couvineau P; Llorens-Cortes C; Iturrioz X
    FASEB J; 2020 Jun; 34(6):7989-8000. PubMed ID: 32301550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
    Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
    Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apelin/APJ system in the regulation of vascular tone: friend or foe?
    Rikitake Y
    J Biochem; 2021 Apr; 169(4):383-386. PubMed ID: 33169143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.